Home Nucleus Pharmaceuticals South Korea Influenza Drug Market to 2032

South Korea Influenza Drug Market to 2032

Overview

The South Korea Influenza Drug Market is expected to reach a 371.41 USD Million by 2032 and is projected to grow at a CAGR of 6.81% from 2025 to 2032.

Revenue, 2024 (USD Million)
242.96
Forecast, 2032 (USD Million)
371.41
CAGR, 2024 - 2032
6.81%
Report Coverage
South Korea

South Korea Influenza Drug Market 2018-2032 USD Million

South Korea Influenza Drug Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 242.96 USD Million
  • Projected Market Size (2032): 371.41 USD Million
  • CAGR (2025-2032): 6.81%

Key Findings of South Korea Influenza Drug Market

  • The South Korea Influenza Drug Market was valued at 242.96 USD Million in 2024.
  • The South Korea Influenza Drug Market is likely to grow at a CAGR of 6.81% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Vaccines in Treatment Segment accounted for the largest share of the market with a revenue of 423.14 USD Million
  • The fastest growing segment Oral in Route of Administration Segment grew Fastest with a CAGR of 7.58% during the forecast period from 2024 to 2032.

South Korea Influenza Drug Market Scope

South Korea Influenza Drug Market Segmentation & Scope
Route of Administration
  • Intravenous
  • Intranasal
  • Intradermal
  • Intramuscular
  • Oral
Age
  • Pediatrics
  • Adults
End User
  • Homecare
  • Hospitals
Distribution Channel
  • Retail Sales
  • Direct Tender
Treatment
  • Drugs
  • Vaccines
Type
  • Influenza C
  • Influenza B
  • Influenza A

South Korea Influenza Drug Market Data Coverage Insights

Study Period 2024-2032
Base Year 2022
Unit Revenue in USD Million
Market Value in 2024 242.96 USD Million
Market Value in 2032 371.41 USD Million
CAGR (2025-2032) 6.81%
Historic Data 2016-2023
Market Segments Covered Route of Administration,Age,End User,Distribution Channel,Treatment,Type

Regional Insights:

  • Leading Market (2024-2032): South Korea, leading in terms of revenue 242.96 USD Million in 2024
    • Key Country: South Korea, leading in terms of revenue with value of 242.96 USD Million in 2024.

Segments and Scope

  • South Korea Influenza Drug Market to 2032, By Route of Administration
    • Oral is the largest segment in South Korea Influenza Drug Market to 2032 with a revenue of 105.95 USD Million in the year 2024.
    • Oral is the Fastest growing segment in South Korea Influenza Drug Market to 2032 with a Growth rate of 7.58 % in forecast period 2025-2032.
  • South Korea Influenza Drug Market to 2032, By Age
    • Pediatrics is the largest segment in South Korea Influenza Drug Market to 2032 with a revenue of 122.57 USD Million in the year 2024.
    • Pediatrics is the Fastest growing segment in South Korea Influenza Drug Market to 2032 with a Growth rate of 7.25 % in forecast period 2025-2032.
  • South Korea Influenza Drug Market to 2032, By End User
    • Hospitals is the largest segment in South Korea Influenza Drug Market to 2032 with a revenue of 176.30 USD Million in the year 2024.
    • Hospitals is the Fastest growing segment in South Korea Influenza Drug Market to 2032 with a Growth rate of 6.98 % in forecast period 2025-2032.
  • South Korea Influenza Drug Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in South Korea Influenza Drug Market to 2032 with a revenue of 135.95 USD Million in the year 2024.
    • Direct Tender is the Fastest growing segment in South Korea Influenza Drug Market to 2032 with a Growth rate of 7.13 % in forecast period 2025-2032.
  • South Korea Influenza Drug Market to 2032, By Treatment
    • Vaccines is the largest segment in South Korea Influenza Drug Market to 2032 with a revenue of 423.14 USD Million in the year 2024.
    • Vaccines is the Fastest growing segment in South Korea Influenza Drug Market to 2032 with a Growth rate of 6.83 % in forecast period 2025-2032.
  • South Korea Influenza Drug Market to 2032, By Type
    • Influenza A is the largest segment in South Korea Influenza Drug Market to 2032 with a revenue of 115.22 USD Million in the year 2024.
    • Influenza A is the Fastest growing segment in South Korea Influenza Drug Market to 2032 with a Growth rate of 7.31 % in forecast period 2025-2032.

South Korea Influenza Drug Market Company Share Analysis

 
Company Name Company Share Analysis
Sanofi
AstraZeneca
GSK plc.
CSL
F. Hoffmann-La Roche Ltd.
South Korea Influenza Drug Market Company Share Analysis

South Korea Influenza Drug Market Geographical Sales Distribution, 2018-2032 USD Million

South Korea Influenza Drug Market Geographical Sales Distribution, 2018-2032 USD Million

South Korea Influenza Drug Market Company Profiling

South Korea Influenza Drug Market Company Profiling

Industry Related Reports

South America Cold Sore Treatment Market
Middle East & Africa Cold Sore Treatment Market
North America Cold Sore Treatment Market
Europe Cold Sore Treatment Market
Asia-Pacific Cold Sore Treatment Market
Argentina Cold Sore Treatment Market
Australia Cold Sore Treatment Market
Austria Cold Sore Treatment Market
Belgium Cold Sore Treatment Market
Brazil Cold Sore Treatment Market
Frequently Asked Questions
The South Korea Influenza Drug Market is segmented based on Segmentation Route of Administration,Age,End User,Distribution Channel,Treatment,Type.
South Korea Influenza Drug Market was valued at USD 242.96(Revenue in USD Million) in 2022.
South Korea Influenza Drug Market is projected to grow at a CAGR of 6.81% during the forecast period of 2024 to 2032.
The Vaccines segment is expected to dominate the South Korea Influenza Drug Market, holding a largest market share of 423.14 USD Million in 2024

South Korea Influenza Drug Market Scope

South Korea Influenza Drug Market Segmentation & Scope
Route of Administration
  • Intravenous
  • Intranasal
  • Intradermal
  • Intramuscular
  • Oral
Age
  • Pediatrics
  • Adults
End User
  • Homecare
  • Hospitals
Distribution Channel
  • Retail Sales
  • Direct Tender
Treatment
  • Drugs
  • Vaccines
Type
  • Influenza C
  • Influenza B
  • Influenza A
Frequently Asked Questions
The South Korea Influenza Drug Market is segmented based on Segmentation Route of Administration,Age,End User,Distribution Channel,Treatment,Type.
South Korea Influenza Drug Market was valued at USD 242.96(Revenue in USD Million) in 2022.
South Korea Influenza Drug Market is projected to grow at a CAGR of 6.81% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Influenza Drug Market for final year is USD 371.41 (USD Million).

South Korea Influenza Drug Market Company Profiling

South Korea Influenza Drug Market Company Profiling
Frequently Asked Questions
The South Korea Influenza Drug Market is segmented based on Segmentation Route of Administration,Age,End User,Distribution Channel,Treatment,Type.
South Korea Influenza Drug Market was valued at USD 242.96(Revenue in USD Million) in 2022.
South Korea Influenza Drug Market is projected to grow at a CAGR of 6.81% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Influenza Drug Market for final year is USD 371.41 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES